MX2017012021A - Compuestos antifungicos y procesos para la fabricacion. - Google Patents

Compuestos antifungicos y procesos para la fabricacion.

Info

Publication number
MX2017012021A
MX2017012021A MX2017012021A MX2017012021A MX2017012021A MX 2017012021 A MX2017012021 A MX 2017012021A MX 2017012021 A MX2017012021 A MX 2017012021A MX 2017012021 A MX2017012021 A MX 2017012021A MX 2017012021 A MX2017012021 A MX 2017012021A
Authority
MX
Mexico
Prior art keywords
processes
making
antifungal compounds
compound
polymorphs
Prior art date
Application number
MX2017012021A
Other languages
English (en)
Inventor
J Hoekstra William
Bonnaud Thierry
Dale Wirth David
EHIWE Tracy
Original Assignee
Viamet Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viamet Pharmaceuticals Inc filed Critical Viamet Pharmaceuticals Inc
Publication of MX2017012021A publication Critical patent/MX2017012021A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00Purification; Separation; Stabilisation; Use of additives
    • C07B63/04Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invención se refiere a formas polimórficas del compuesto 1 o 1a y procesos para preparar polimorfos del Compuesto 1 y 1a, que son útiles como agentes antifúngicos. En particular, la invención trata de proporcionar una nueva metodología para la preparación de polimorfos del compuesto 1 y derivados sustituidos de los mismos.
MX2017012021A 2015-03-19 2016-03-17 Compuestos antifungicos y procesos para la fabricacion. MX2017012021A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562135682P 2015-03-19 2015-03-19
PCT/US2016/022858 WO2016149486A1 (en) 2015-03-19 2016-03-17 Antifungal compounds and processes for making

Publications (1)

Publication Number Publication Date
MX2017012021A true MX2017012021A (es) 2018-01-30

Family

ID=56919372

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017012021A MX2017012021A (es) 2015-03-19 2016-03-17 Compuestos antifungicos y procesos para la fabricacion.

Country Status (19)

Country Link
US (4) US9840492B2 (es)
EP (1) EP3271347B1 (es)
KR (1) KR102603277B1 (es)
CN (1) CN107428724B (es)
AU (1) AU2016233113B2 (es)
BR (1) BR112017018823A2 (es)
CA (1) CA2978339C (es)
DK (1) DK3271347T3 (es)
EA (1) EA037556B1 (es)
ES (1) ES2926063T3 (es)
HR (1) HRP20221113T1 (es)
HU (1) HUE059771T2 (es)
LT (1) LT3271347T (es)
MX (1) MX2017012021A (es)
PL (1) PL3271347T3 (es)
PT (1) PT3271347T (es)
RS (1) RS63566B1 (es)
SI (1) SI3271347T1 (es)
WO (1) WO2016149486A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3351541A1 (en) 2011-12-11 2018-07-25 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
JP6613391B2 (ja) 2014-03-19 2019-12-04 ブイピーエス‐3,インコーポレイテッド 2−(2,4−ジフルオロフェニル)−1,1−ジフルオロ−1−(5−置換ピリジン−2−イル)−3−(1h−テトラゾール−1−イル)プロパン−2−オールおよびその調製工程
CA2942932A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
CN106132947B (zh) * 2014-03-19 2019-08-09 Vps-3有限公司 化合物的制备方法
EP3119755B1 (en) 2014-03-19 2019-03-06 Viamet Pharmaceuticals (NC), Inc. Antifungal compound process
CA2942968C (en) 2014-03-19 2022-03-15 William J. Hoekstra Antifungal compound process
WO2015143166A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
JP2017514790A (ja) 2014-03-19 2017-06-08 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
WO2015143142A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
KR20160138013A (ko) 2014-03-19 2016-12-02 비아멧 파마슈티컬즈, 인코포레이티드 항진균 화합물 제조방법
CA2978339C (en) * 2015-03-19 2021-08-03 Viamet Pharmaceuticals, Inc. Antifungal compounds and processes for making
EA038214B1 (ru) 2015-09-18 2021-07-23 Майковиа Фармасьютикалс, Инк. Способ получения противогрибковых соединений
WO2021188404A1 (en) * 2020-03-19 2021-09-23 Assia Chemical Industries Ltd Solid state forms of oteseconazole and process for preparation thereof
WO2023003554A1 (en) * 2021-07-22 2023-01-26 Mycovia Pharmaceuticals, Inc. Compositions comprising oteseconazole
TW202423418A (zh) * 2022-09-30 2024-06-16 大陸商上海濟煜醫藥科技有限公司 雙環類化合物的無定形、結晶固體及其製備方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4921475A (en) 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
IE66203B1 (en) 1989-12-04 1995-12-13 Searle & Co System for transdermal albuterol administration
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
EP0617665B1 (en) 1991-12-18 1999-03-31 Minnesota Mining And Manufacturing Company Multilayered barrier structures
EP0553769B1 (de) 1992-01-29 1996-01-03 FRANZ VÖLKL GmbH & CO. SKI UND TENNIS SPORTARTIKELFABRIK KG Ballspielschläger, insbesondere Tennisschläger
ES2498370T5 (es) * 2002-05-16 2021-11-24 Janssen Sciences Ireland Unlimited Co Formas pseudopolimórficas de un inhibidor de la proteasa de VIH
EP1951705A4 (en) * 2005-10-31 2010-12-15 Dae Woong Pharma NEW ANTIFUNGAL TRIAZOLE DERIVATIVES
DE102008043697A1 (de) 2008-01-25 2009-07-30 Robert Bosch Gmbh Verfahren und Vorrichtung zur Bestimmung der Zusammensetzung eines Kraftstoffgemischs
EA024341B1 (ru) 2010-04-24 2016-09-30 Ваймет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
DK2804858T3 (da) * 2012-01-20 2020-03-16 Mycovia Pharmaceuticals Inc Metalloenzym-inhibitorforbindelser
WO2013110002A1 (en) * 2012-01-20 2013-07-25 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
ITFI20120143A1 (it) * 2012-07-12 2014-01-13 Inalco S A S Di Giovanni Cipollett I & C Polimorfi idrati e anidri del 2'-o-fucosillattosio e loro metodi di produzione.
CA2942968C (en) 2014-03-19 2022-03-15 William J. Hoekstra Antifungal compound process
CA2978339C (en) * 2015-03-19 2021-08-03 Viamet Pharmaceuticals, Inc. Antifungal compounds and processes for making

Also Published As

Publication number Publication date
BR112017018823A2 (pt) 2018-04-24
US10676459B2 (en) 2020-06-09
US20190210994A1 (en) 2019-07-11
AU2016233113B2 (en) 2020-05-07
PL3271347T3 (pl) 2022-11-21
SI3271347T1 (sl) 2022-11-30
WO2016149486A1 (en) 2016-09-22
HRP20221113T1 (hr) 2022-11-25
CN107428724B (zh) 2021-07-02
HUE059771T2 (hu) 2022-12-28
KR20170129895A (ko) 2017-11-27
EP3271347A1 (en) 2018-01-24
EA037556B1 (ru) 2021-04-14
PT3271347T (pt) 2022-07-14
US20190367476A1 (en) 2019-12-05
EA201792067A1 (ru) 2018-01-31
US20180319768A1 (en) 2018-11-08
EP3271347B1 (en) 2022-06-22
US10414751B2 (en) 2019-09-17
AU2016233113A1 (en) 2017-09-21
CA2978339C (en) 2021-08-03
LT3271347T (lt) 2022-10-10
DK3271347T3 (da) 2022-07-18
US9840492B2 (en) 2017-12-12
US10370353B2 (en) 2019-08-06
CA2978339A1 (en) 2016-09-22
KR102603277B1 (ko) 2023-11-17
EP3271347A4 (en) 2018-10-17
CN107428724A (zh) 2017-12-01
US20170121307A1 (en) 2017-05-04
ES2926063T3 (es) 2022-10-21
RS63566B1 (sr) 2022-10-31

Similar Documents

Publication Publication Date Title
MX2017012021A (es) Compuestos antifungicos y procesos para la fabricacion.
MX2018003284A (es) Compuestos antifungicos y procesos para hacerlos.
MX2020004504A (es) Derivados de fenoximetilo.
SG10201809518QA (en) Processes of preparing a jak1 inhibitor and new forms thereto
MX365494B (es) Procedimiento de compuesto antifungico.
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
MX2016012053A (es) Procedimiento de compuesto antifungico.
MY183123A (en) Synthesis of copanlisib and its di hydrochloride salt
HK1258964A1 (zh) 用於製備1,3-苯並間二氧雜環戊烯雜環化合物的方法
IL260011B (en) History of water-soluble 5,3-diphenyldiazole compounds
WO2016166720A3 (en) Polymorphs of afatinib and its salts and process for the preparation of quinazolinyl derivatives
HK1256825A1 (zh) 取代的5,6-二氫-6-苯基苯並[f]異喹啉-2-胺化合物的固體形式
MX2017011389A (es) Proceso para la preparacion de 3-cloro-2-vinilfenilsulfonatos.
MX2017002689A (es) Nuevos compuestos de sulfonilaminobenzamida como antihelminticos.
HUE042626T2 (hu) Eljárások a medetomidin szintézisnél hasznosítható vegyületek, például 3 aril-butiral-dehidek elõállítására
PL3515454T3 (pl) Krystaliczna polimorficzna postać 3-hydroksy-4,5-bis-benzyloksy- 6-benzyloksymetylo-2-fenylo-2-okso-2lambda5-[1,2]oksafosfinanu
SG11202003286YA (en) Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
JO3639B1 (ar) صورة متعددة الشكل جديدة لـ n-[2-(6-فلورو-1h-إندول-3-يل)إيثيل]-3-(2،2،3،3-تترا فلورو بروبوكسي)بنزيل أمين هيدروكلوريد
MX2017011388A (es) Proceso para la preparacion de derivados de fenilisoxazolina sustituida.
IN2014CH01257A (es)